ScholarIQanswers from OpenAlex & ORCID
Dana Y. Teltsch
ResearcherPublications, citations & collaboration network
Dana Y. Teltsch is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Dana Y. Teltsch have?
ScholarIQindexed works
Dana Y. Teltsch has 26 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Dana Y. Teltsch have?
ScholarIQcitation count
Dana Y. Teltsch has 310 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Dana Y. Teltsch?
ScholarIQh-index
Dana Y. Teltsch has an h-index of 8 in OpenAlex.
What is the i10-index of Dana Y. Teltsch?
ScholarIQi10-index
Dana Y. Teltsch has an i10-index of 8 in OpenAlex.
What is the OpenAlex record for Dana Y. Teltsch?
ScholarIQopenalex
The OpenAlex for Dana Y. Teltsch is on the source record.
What are the most-cited papers on Dana Y. Teltsch?
ScholarIQmost cited works
Infection Acquisition Following Intensive Care Unit Room Privatization
Dana Y. Teltsch, James A. Hanley, Vivian G. Loo, Peter Goldberg, Ash Gursahaney, David L. Buckeridge
Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres
Don Robinson, Matthew W. Reynolds, Corey Casper, Angela Dispenzieri, Jessica Vermeulen, Krista Payne, J Schramm, Kay M. Ristow, Marie-Pierre Desrosiers, Karen Yeomans, Dana Y. Teltsch, Richard S. Swain, Thomas M. Habermann, Philip Rotella, Helgi van de Velde
Incident gout and chronic Kidney Disease: healthcare utilization and survival
Dena H. Jaffe, Alyssa Klein, Arriel Benis, Natalia M. Flores, Hagit Gabay, Robert Morlock, Dana Y. Teltsch, Jonathan Chapnick, Yair Molad, Shmuel Giveon, Becca Feldman, Maya Leventer‐Roberts
Development and validation of algorithms to identify newly diagnosed type 1 and type 2 diabetes in pediatric population using electronic medical records and claims data
Dana Y. Teltsch, Soulmaz Fazeli Farsani, Richard S. Swain, Stefan Kaspers, Samuel Huse, Christina L Cristaldi, Beth Nordstrom, Kimberly G. Brodovicz
Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma
Sandy Srinivas, Dara Stein, Dana Y. Teltsch, Sunning Tao, Laura A. Cisar, Krishnan Ramaswamy